FDA Adverse Event Malfunction Summary report: N

TROPONIN I (TPI) IMMULITE 2000

MDR report key: 8708085 · Received June 18, 2019

Report

Report Number
2432235-2019-00215
Event Type
Malfunction
Date Received
June 18, 2019
Date of Event
May 29, 2019
Report Date
July 5, 2019
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
Product Code
MMI
PMA / PMN Number
K983972
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

SIEMENS FILED THE INITIAL MDR 2432235-2019-000215 ON 18-JUN-2019. ADDITIONAL INFORMATION (24-JUN-2019): SIEMENS INVESTIGATION IDENTIFIED THAT THE ORIGINAL TROPONIN KIT LOT 294 WAS WITHIN THE STATED ON-BOARD STABILITY AND NO OTHER PATIENT SAMPLES WERE RUN USING KIT LOT 294 ON THE DAY OF THE EVENT, AT THE SITE LISTED IN THE COMPLAINT. QUALITY CONTROL (QC) WAS ELEVATED AT THE TIME THE DISCORDANT RESULTS WERE RUN ON THIS PACK. NO OTHER TESTS WERE REPORTED AS AN ISSUE ON THE SYSTEM WHICH RAN THE DISCORDANT TROPONIN RESULT, THEREFORE AN INSTRUMENT ISSUE IS NOT SUSPECTED NOR IS A PRE-ANALYTICAL ISSUE BECAUSE THE SAMPLES REPRODUCED AS ELEVATED ON KIT LOT 294. SIEMENS REVIEWED THE COMPLAINT DATABASE AND DETERMINED THAT THERE WERE NO SIMILAR COMPLAINTS FOUND FOR KIT LOT 294. WHILE THE CAUSE OF THE INITIALLY REPRODUCIBLE FALSELY ELEVATED RESULTS CANNOT BE DETERMINED, SIEMENS CANNOT RULE OUT SHIPPING/HANDLING/STORAGE OF THE PACK OF KIT LOT 294. THE COMPLAINT WAS RESOLVED BY PERFORMING ROUTINE TROUBLESHOOTING. NO PRODUCT PERFORMANCE ISSUE IS CONFIRMED BECAUSE THIS HAS NOT BEEN DETERMINED TO BE A SYSTEMIC ISSUE. THE CUSTOMER IS OPERATIONAL ON KIT LOT 295. SECTION H6: RESULTS AND CONCLUSION CODES ARE UPDATED.

Additional Manufacturer Narrative · 1

THE CUSTOMER CONTACTED A SIEMENS CUSTOMER CARE CENTER (CCC) AND REPORTED THAT THEY OBTAINED DISCORDANT, FALSELY ELEVATED TROPONIN I (TPI) RESULTS ON AN IMMULITE 2000 XPI INSTRUMENT. THE CAUSE FOR THE DISCORDANT, FALSELY ELEVATED TPI RESULTS IS UNKNOWN. IT WAS DETERMINED THAT THE LEVEL 2 QUALITY CONTROL (QC) WAS ELEVATED OUTSIDE THE INSERT RANGES DURING THE TIME OF THE RUNS ON ASSAY KIT LOT # 294. SIEMENS IS INVESTIGATING THE ISSUE.

Description of Event or Problem · 1

THE CUSTOMER OBTAINED A FALSELY ELEVATED TROPONIN I (TPI) RESULT ON A PATIENT SAMPLE ON AN IMMULITE 2000 XPI INSTRUMENT, USING KIT LOT 294. THE CUSTOMER RECALIBRATED THE KIT LOT 294 AND REPEATED THE SAME SAMPLE ON THE SAME INSTRUMENT IN DUPLICATE, AND BOTH REPEAT RESULTS WERE ALSO FALSELY ELEVATED. THE INITIAL RESULTS WERE NOT REPORTED TO THE PHYSICIAN(S). THE CUSTOMER CHANGED TO KIT LOT 295 AND REPEATED THE SAME SAMPLE IN DUPLICATE ON THE SAME INSTRUMENT, WITH BOTH RESULTS COMING OUT LOWER AND AS EXPECTED. THE RESULTS FROM KIT LOT 295 WERE REPORTED TO THE PHYSICIAN(S). THERE ARE NO REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT TPI RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
503050 TROPONIN I (TPI) IMMULITE 2000 TROPONIN I (TPI) IMMULITE 2000 MMI SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED TROPONIN I IMMULITE 2000 294

Patients

Seq Age Sex Outcome Treatment
1